Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Maike Stegemann
Institutions:
Johannes Kepler University of Linz,
Kepler Universitätsklinikum
Observed institutions:
Johannes Kepler University of Linz,
Kepler Universitätsklinikum
ORCID:
0009-0007-3961-9344
Observed ORCID:
0009-0007-3961-9344
OpenAlex ID:
A5018021181
Humoral and cellular immune responses in SARS-CoV-2 mRNA-vaccinated patients with cancer
2021
·
Mario Mairhofer
, Lea Kausche
, et al.
·
Cancer Cell
·
63
PDF
DLBCL 1L—What to Expect beyond R-CHOP?
2022
·
Maike Stegemann
, Sophy Denker
, et al.
·
Cancers
·
44
PDF
Cell-based immune anticipation of the omicron variant in SARS-CoV-2 triple-vaccinated cancer patients
2025
·
Mario Mairhofer
, Lea Kausche
, et al.
·
iScience
·
1
Highlights from the 2025 ASH meeting: what’s new in lymphoma?
2026
·
Maike Stegemann
, Clemens A. Schmitt
·
memo - Magazine of European Medical Oncology
PDF
Simultaneous auto-transplant and CD19 CAR T-cell 2nd line therapy followed by CD20 × CD3 bispecific antibody for refractory Burkitt lymphoma, a case report
2025
·
Maike Stegemann
, Sigrid Macherndl-Spandl
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
Cell-based immune anticipation of the omicron variant in SARS-CoV-2 triple-vaccinated cancer patients
2025
·
Mario Mairhofer
, Lea Kausche
, et al.
·
iScience
Show more works
View as search
Works count:
6
Citation count:
108
H-index:
2
I10-index:
2
Year
Topic
Type